New Research Peptides: The Latest Additions to Our Catalog
This category shows what we added most recently and what researchers are searching for now. Each product has its own documentation, and we describe the evidence honestly, including where it runs thin. We test every batch by HPLC and mass spectrometry and attach a lot matched COA to each vial.
Latest Additions
CBL-514 leads the list, in 5 mg, 10 mg, and 20 mg sizes. It is an injectable fat cell compound in Phase 3 trials, and Phase 2 data showed reductions in abdominal fat. We also feature SS-31, tesamorelin, and hexarelin.
What “Trending” Means Here
Trending describes search interest, not proof of effect. Two of these compounds, SS-31 and tesamorelin, are approved medicines in narrow indications under other names, and our vials are not those medicines. CBL-514 remains investigational, with Phase 3 results expected in 2027.
Quality Standards
Every product ships with an HPLC result, a mass spectrometry identity test, and a lot matched COA. Orders placed before 2pm ship the same day. We label everything for research use only.
Regulation
We sell all products strictly as research compounds, not for human or veterinary use. Check the FDA compounding page for current rules.
Related Categories
Browse the Weight and Metabolism category or the Sleep and Growth Hormone category.
FAQ
What is CBL-514?
It is an investigational injectable that triggers fat cell death, currently in Phase 3 trials.
Is CBL-514 approved?
It remains investigational.
How often do you add products?
Check this page regularly for new additions.
-
MOTS-c Buy
Price range: $40.00 through $80.00





